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Abstract
AIM: To test the clinical significance of antineutrophil
cytoplasmic antibody (ANCA) in evaluation of adult
Henoch-Schönlein purpura (HSP) patients presenting
mainly with abdominal symptoms.
METHODS: Twenty-eight consecutive HSP patients who
presented predominantly with abdominal symptoms were
enrolled in this study. Control subjects included 27 ageand sex-matched patients with peptic ulcer disease, colon
cancer, acute gastroenteritis, irritable bowel syndrome
and colonic polyps. ANCA was measured by indirect
immunofluorescence (IIF) in all patients, and follow-up
ELISA was performed in patients with positive IIF tests.
RESULTS: ANCA was detected in 9 HSP patients by
IIF (2 were positive for c-ANCA and 7 were positive for
p-ANCA). No ANCA was found in the control group. The
sensitivity and specificity of a positive ANCA test (either
c- or p-ANCA) were 32.1% and 100% respectively.
Only one out of the 9 patients with positive ANCA by
IIF had positive ANCA by ELISA and the antigen was
myeloperoxidase (MPO). The patients positive for ANCA
had higher HSP clinical scores, and were more likely
to have renal function impairment. Patients with late
purpura development were also associated with more
severe clinical manifestations.
CONCLUSION: A positive ANCA test is associated with
more severe symptoms in HSP. After inflammatory bowel
disease is excluded, a positive ANCA test provides a clue
to the diagnosis of HSP presenting predominantly with
abdominal symptoms.

www.wjgnet.com

© 2008 WJG . All rights reserved.

Key words: Henoch-Schönlein purpura; Antineutrophil
cytoplasmic antibody; Diagnosis; Indirect immunofluorescence
Peer reviewers: Stephen E Roberts, Senior Lecturer in

Epidemiology, School of Medicine, Swansea University, Honorary
Research Fellow, Department of Public Health, University of
Oxford, School of Medicine, Swansea University, Singleton
Park, Swansea SA2 8PP, United Kingdom; Damian Casadesus
Rodriguez, MD, PhD, Calixto Garcia University Hospital, J and
University, Vedado, Havana City, Cuba
Zhang Y, Wu YK, Ciorba MA, Ouyang Q. Significance of
antineutrophil cytoplasmic antibody in adult patients with
Henoch-Schönlein purpura presenting mainly with gastrointestinal
symptoms. World J Gastroenterol 2008; 14(4): 622-626 Available
from: URL: http://www.wjgnet.com/1007-9327/14/622.asp DOI:
http://dx.doi.org/10.3748/wjg.14.622

INTRODUCTION
Abdominal pain, diar rhea, hematochezia are the
common symptoms seen in clinical gastroenterology.
The underlying causes may not always be clear. HenochSchönlein purpura (HSP) is one of the uncommon
causes and can be a challenging clinical problem [1] .
Among the presenting symptoms, gastrointestinal (GI)
complains occur in 50% to 85% of patients[2]. Some HSP
patients may develop serious GI complications, such as
intussusception, obstruction and perforation, which may
require surgical intervention on rare occasions[3-5]. Early
diagnosis of HSP presenting mainly with acute abdominal
symptoms in adults remains a challeng e to both
gastroenterologists and general surgeons, particularly if
the abdominal symptoms precede the typical skin rash.
Although HSP is more common in children, it has also
been documented in adults[6]. In comparison to children,
adult patients have more atypical symptoms and a poorer
prognosis and need more intensive care[7]. Although lots
of efforts have been made, the mortality in adults with
HSP is still higher than that in children. Doctors are
eager to find a more effective therapy for the disease.
Since antineutrophil cytoplasmic antibody (ANCA)
was reported in 1982 by Bavis, many studies have shown
that ANCA is a useful tool for the diagnosis of systemic
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vasculitis, especially for the diagnosis and follow-up of
microscopic polyangiitis and Wegener’s granulomatosis[8,9].
It was reported that ANCA is also detectable in patients
with HSP. However, the prevalence of HSP remains
controversial, ranging 0%-79%[10-13]. It has been shown that
the positive ANCA rate is as high as 82.3%[14], suggesting
that ANCA can be used to confirm the diagnosis of
HSP in children. In addition, some reports indicate that
ANCA is also related to the severity of autoimmunological
diseases, such as Wegener’s granulomatosis[15], systemic
vasculitis[16,17]. However, the relationship between ANCA
and the severity of HSP has not been extensively
investigated.
Till now, most studies were confined to children, only a
few studies have been done in adults[12,13] and no reports on
adult HSP patients presenting mainly with gastrointestinal
symptoms are available. The aim of this study was to
evaluate the clinical significance of ANCA in adult HSP
patients who presented mainly with gastrointestinal
symptoms and its role in the diagnosis of HSP and its
relationship to the disease severity.

MATERIALS AND METHODS
Patient selection
From February 2003 to March 2006, all adult HSP patients
(age > 20 years) with prominent gastrointestinal symptoms,
admitted to West China Hospital of Sichuan University,
were enrolled in the study. All the patients fulfilled the HSP
diagnostic criteria[18]. During the same period, non-HSP
inpatients with similar gastrointestinal symptoms served
as the control group. Only patients without preexisting
medical comorbidity were included in this study. Patients
with known inflammatory bowel disease or autoimmune
diseases were excluded from the study.
ANCA detection by indirect immunofluorescence (IIF)
The method is commercially established and provided
by EUROIMMU Company (Germany). Briefly, serum
samples were diluted at 1:3.2 in a phosphate- buffered
solution (PBS), then 25 µ L was applied to slides, and
incubated at room temperature for 30 min. After the
slides were washed with PBS, 20 µL FITC-labeled affinitypurified goat anti-human IgG (EUROIMMU Company,
Germany) was applied to the slides and incubated at room
temperature for 30 min. Fluorescence microscopy was
performed and the results were interpreted as negative
for lack of fluorescence and positive for the presence of
moderate or intense fluorescence.
ANCA detection by ELISA for PR-3, MPO, EL, Cath-G, LF
and BPI
The ELISA kit from EUROIMMU Company (Germany)
was used. Briefly, 100 µL of patient serum diluted at 1:100,
positive and negative controls were put in 96-well plates
(coated with PR-3, MPO, EL, Cath-G, LF or BPI) and
incubated at room temperature for 30 min. After washed
with PBS, 100 µ L enzyme-labeled rabbit antihuman
IgG (EUROIMMU Company, Ger many) was added
to the wells and incubated for 30 min. After washing,
100 µL enzyme substrate (TMB/H2O2) was added to the

623

Table 1 Clinical scores for HSP
Symptom
Purpura
below the umbilicus
above the umbilicus
Abdominal pain
Stool occult blood < 2+
Stool occult blood > 2+
Joint pain
Renal involvement
Urinary occult blood 1+
Urinary occult blood 2+
Urinary occult blood 3+

Score
1+
2+
1+
2+
1+
1+
2+
3+

wells, and incubated for 15 min. The reaction was then
terminated by adding 100 µL sulfuric acid (0.5 mol/L).
The absorbance was read at 450 nm with an automated
plate reader. The result was expressed as (serum sample
OD-OD of negative control)/[(C-blank OD) × 0.2)].
A value < 0.1 was regarded as negative and ≥ 0.1 as
positive.
Other biochemical examinations
Twenty four-hour urinary protein, urinalysis, kidney function
and antinuclear antibody (ANA) test and rheumatoid factor
(RF) were performed in the clinical laboratory of the
hospital.
HSP clinical score
To stratify patients according to the disease severity, the
clinical scoring system of was used as previously described
Table 1[19].
Statistical analysis
Results were given as mean ± SD and percentage. For
statistical analysis, Student t test (for age, clinical scores,
blood creatine, 24 h urinary protein) and χ2 test (for sex
and clinical symptom percentages) were used. P < 0.05 was
considered statistically significant.

RESULTS
Twenty-eight patients with a final diagnosis of HSP
who presented mainly with gastrointestinal symptoms
were included in the study. All HSP patients eventually
developed typical purpura lesions. The average clinical
score was 5.32 ± 0.92. Twenty-seven patients with peptic
ulcer (n = 10), colon cancer (n = 1), acute gastroenteritis
(n = 6), irritable bowel syndrome (n = 6), and colonic
polyps (n = 4) served as controls. Age and sex distribution
were comparable between the two groups (P > 0.05). The
demographics, symptom percentages in both groups are
listed in Table 2.
All the patients were negative for ANA. Only one
HSP patient was found to have a positive RF test. Of the
23 patients who could recall the occurring time of their
symptoms, 5 complained of GI symptoms preceding
purpura while 18 complained of purpura preceding the GI
symptoms.
ANCA was detected in 9 HSP patients. Of them, 2 had
www.wjgnet.com
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Table 2 Comparison of demographic data between HSP
patients and controls

n
Gender (male/female)
Age (yr) (mean ± SD)
Age range (yr)
Symptoms
Abdominal pain (%)
Hematochezia (%)
Diarrhea (%)
Vomiting (%)

HSP

Control

P value

28
15/13
29.8 ± 8.1
20-46

27
11/16
30.1 ± 8.6
22-52

NS1
NS
NS

53.6
46.4
21.4
10.7

59.8
51.2
32.1
14.8

NS
NS
NS
NS
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Table 3 ANCA detected by IIF in HSP patients and controls
+ANCA by IIF

- ANCA by IIF

9
0

19
27

HSP
control

Table 4 Blood creatine and 24 h urinary protein in HSP
patients (mean ± SD)

ANCA (+)
ANCA (-)

1

NS denotes no significance.
b

Blood creatine (μmol/L)

24 h urinary protein (g/L)

320 ± 22 (3.64 ± 0.25 mg/dL)
104 ± 15b (1.19 ± 0.16 mg/dL)

1.78 ± 0.12
0.78 ± 0.32c

P = 0.01, cP = 0.03.

A
Table 5 Characteristics of the two groups
Symptom
sequence
Purpura before
abdominal
symptoms
Purpura after
abdominal
symptoms

B

Figure 1 Strong cytoplasmic (A) and nuclear (B) staining patterns of ANCA
(C-ANCA and P-ANCA) detected by indirect IIF. Serum samples from patients
were diluted and incubated with primary antibody, then with FITC-labeled affinitypurified goat anti-human IgG. The results were observed under fluorescence
microscope.

C-ANCA (Figure 1A) and 7 had P-ANCA (Figure 1B).
No ANCA was detected in the controls (Table 3). The
sensitivity and specificity of positive ANCA were 32.1%
and 100% respectively. ELISA was performed for the 9
patients with positive ANCA detected by indirect IIF. Only
one patient was positive for ANCA and the antigen was
myeloperoxidase (MPO).
HSP patients who were positive for ANCA had higher
clinical scores (6.79 ± 0.72 vs 4.12 ± 0.63, P = 0.02), and
a higher rate for renal involvement as indicated by serum
creatine level and 24 h urinary protein at the time of
diagnosis (Table 4). Baseline kidney function tests were
not available for most patients. However, given the lack of
preexisting medical conditions, HSP was the most likely
www.wjgnet.com

Positive
ANCA (%)

HSP
score

Abdominal Diarrhea Hematochezia
pain (%)
(%)
(%)

33.3

5.02 ± 1.23

55.6

22.2

38.9

40.0

6.23 ± 1.08

60.0

40.0

60.0

culprit for renal impairment in these patients.
HSP clinical scores and ANCA positive rates in patients
with early and late purpura were also analyzed (Table 5).
The latter was associated with a higher clinical score, but
the GI symptoms and ANCA positive rate were similar in
the two groups.
Typical case presentation
Case 1: A 28-year-old male was admitted for vomiting and
diarrhea for 5 d and oliguria for 1 d. Physical examination
on admission showed mild tenderness in the mid upper
abdomen. Stool analysis showed white blood cells (+) and
red blood cells (+). Renal function test showed moderately
elevated blood BUN and creatine. Urinary analysis showed
occult blood (++). “Acute gastroenteritis and acute renal
function failure” were the initial diagnosis on admission.
Infusion of 2 liters of intravenous fluid did not result in any
clinical improvement. Serum ANCA test was positive. Three
days later, typical purpura appeared on his lower extremities
and HSP was thus diagnosed. The symptoms disappeared
after one-month intravenous cyclosporine therapy.
Case 2: A 26-year-old male was admitted for abdominal
pain and hematochezia for 4 d, and hematuria for 1 d.
Physical examination was normal. Blood examination
showed moderate anemia. Urinalysis showed red blood
cells (++). Renal ultrasound was nor mal. An upper
endoscopy showed edema and congestion in the pyloric
region (Figure 2A). Colonoscopy showed several petechiae
scattering throughout the colon (Figure 2B). ANCA test
was positive. Four days later, typical purpura appeared in
his hips and lower extremities. All symptoms disappeared
three weeks after treatment with prednisone.
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DISCUSSION
HSP is an immune-complex mediated vasculitis, affecting
small vessels in skin, gut and glomeruli[20] and is characterized
by polymorphonuclear leukocytic infiltration of the vessel
wall. Mucosal lesions of HSP can occur anywhere in
the GI tract, and the small intestine is unfortunately the
most commonly affected[21,22]. In 10%-15% HSP patients,
gastrointestinal symptoms precede the cutaneous lesions[23].
The GI manifestation in these patients is usually severe and
sometimes requires laparotomy. Our study also showed that
the patients with GI symptoms preceding the purpura had
higher clinical scores, but unfortunately their GI symptoms
were nonspecific.
ANCA is an auto-antibody existing in peripheral blood,
and has a high specificity for and sensitivity to certain
vasculitis. Saulsbury tested ANCA in 29 HSP patients and
none was positive[10], suggesting that ANCA is not a useful
diagnostic tool for HSP. Renato and Robson et al[11,12] have
also found a low prevalence of ANCA in HSP, indicating that
ANCA is not related to HSP. On the contrary, it was reported
the prevalence (79%) of ANCA is high in HSP patients[13,24].
Faith et al[14] also showed that IgA ANCA is 82.3% in children
with HSP, demonstrating that ANCA is a useful test to
confirm the diagnosis of HSP in children. In our study, the
specificity and sensitivity of ANCA were 100% and 32.1%,
respectively. Due to its high specificity, a positive test result
can be very helpful in making the early diagnosis of HSP
before cutaneous lesions occur. However, our study excluded
ulcerative colitis (UC) patients. According to recent studies,
ANCA is recorded in 50%-70% of patients with UC[25].
Because UC has its own characteristic clinical manifestations,
especially specific colonoscopic manifestation, it is very easy
for GI doctors to differentiate UC from HSP.
The reasons why the reported results are different may
be as follows. (1) IIF is a crude test method its results may
be affected by many factors such as RF and fibronectin,
and interfered with the different process and conditions
of the study. In our study, RF was found only 1 patient,
suggesting that it is not the reason why ANCA test was
positive in our study. (2) Specific antigens are insufficient.
The main target antigens of ANCA lay in the azurophil
granules of neutrophils. Only five specific antigens have
been identified so far for ANCA, including proteinase 3
(PR-3), myeloperoxidase (MPO), leukocyte elastase (EL),
cathepsin G (CG), lactoferrin (LF)[26]. In our study, we
tested the binding of the five antigens to ANCA by ELISA.
The result showed that only one HSP serum sample had
reactivity against anti-MPO, which is in agreement with
previous reports, indicating that the five antigens are not
specific antigens for ANCA. However, little is known about
the specific antigens for ANCA. Ronda et al[13] analyzed the
target antigen by Western blot using four strongest ANCA
positive serum samples and found that a 51-kDa protein can
be recognized in the neutrophil extract, indicating that the
target antigens of ANCA may be different in patients with
HSP and vasculitis. Discovery of more specific antigens for
ANCA is needed to improve its value for clinical utilization.
(3) It also may be related to the selection bias of cases.
Some studies showed that different expressions of HLA are
interfered with the expression of ANCA.
Our results show that a positive ANCA test was
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A

B

Figure 2 Gastroendoscopy showing edema and congestion in the pyloric region
(A) and several petechiae scattering throughout the colon (B).

associated with a higher HSP score and a higher rate for renal
dysfunction and urinary abnormality, which is consistent with
the data reported by Shaw and Esnault[27,28], who found that
patients with worse kidney function and higher urinary protein
level have a higher ANCA titer, showing that ANCA is related
to the activity of HSP. These findings suggest that ANCA
may take part in the pathogenesis of HSP. The presence of
ANCA in the sera of patients may exert both stimulatory and
inhibitory effects on neutrophil and monocyte functions. It
can stimulate the oxidative burst and degranulation, leading
to the release of reactive oxygen intermediates. Enzymes
from granules may directly damage the target tissues,
inhibit the microbicidal activity of polymorphonuclears,
thus aggravating the neutrophil/macrophage dysfunction
by inadequate elimination of the infectious agents[29]. This
may lead to the Th1/Th2 lymphocyte imbalance, leading to
tissue damage and perpetuation of chronic inflammation. In
addition, ANCA may influence the process of physiologic cell
death. It was reported that ANCA can induce apoptosis of
neutrophils, phagocytosis of apoptotic neutrophils opsonized
by ANCA induces oxidative metabolism of monocytes, and
defective apoptosis of neutrophils may thus exacerbate the
tissue damage[30].
In conclusion, after exclusion of UC, a positive ANCA
test in patients presenting mainly with GI symptoms can
provide a clue to the diagnosis of HSP. Patients with a
positive ANCA develop more severe symptoms and are
more likely to have their kidneys involved. HSP patients
with positive ANCA initially presenting with only GI
symptoms should receive a more aggressive therapy. Since
our sample was small, further studies are needed to find
the exact antigens for ANCA in HSP patients.
www.wjgnet.com
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